Abiopharma

🔍 Noonan Daniel (Executive)

Company: COHEN & STEERS, INC. (CNS)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Sold 3,614 shares of Common Stock at $77.05 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 28,682.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 4,360 shares of Common Stock at $77.33 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: Represents the withholding by the issuer of shares of common stock in connection with the reporting person's tax obligations upon the vesting of previously reported restricted stock units ("RSUs") and delivery of the common stock underlying such RSUs.
• F2: Immediately following the delivery of the common stock underlying the RSUs described in footnote 1, the 3,465 shares of common stock so delivered were immediately transferred to the Daniel A. Noonan Revocable Trust. Such transfer was exempt from reporting under Rule 16a-13.
• F3: Represents the weighted average price. These shares were sold in a series of transactions at prices ranging from $77.16 to $77.40. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information relating to the number of shares sold at each separate price within the range set forth in this footnote.
• F4: Shares held by the Daniel A. Noonan Revocable Trust, a revocable trust, of which Mr. Noonan and an immediate family member serve as trustees.